Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis

Lung Cancer

Volumn 54, Issue 3, 2006, Pages 267-283

  Kiyohara, Chikako ^a   Takayama, Koichi ^a   Nakanishi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

BER; Genetic polymorphism; Lung cancer; Meta analysis; Molecular epidemiology

Indexed keywords

8 HYDROXYGUANINE; CARCINOGEN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA GLYCOSYLTRANSFERASE; NUCLEOTIDE; PHOSPHODIESTERASE I; SPLEEN EXONUCLEASE;

8 OXOGUANINE DNA GLYCOSYLASE GENE; AMINO ACID SUBSTITUTION; APURINIC APYRIMIDINIC ENDONUCLEASE GENE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CIGARETTE SMOKING; CLINICAL TRIAL; DNA BINDING; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ETHNOLOGY; EXCISION REPAIR; EXON; GENE; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; JAPAN; LUNG CANCER; META ANALYSIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; X RAY CROSS COMPLEMENTING GROUP 1 GENE;

DNA GLYCOSYLASES; DNA REPAIR; DNA REPAIR ENZYMES; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33750311904     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.08.009     Document Type: Review

References (105)

1. Pharoah P.D., Dunning A., Ponder B.A., and Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4 (2004) 850-860
2. Wood R.D., Mitchell M., and Lindahl T. Human DNA repair genes, 2005. Mutat Res 577 (2005) 275-283
3. Cleaver J.E. Defective repair replication of DNA in xeroderma pigmentosum. Nature 218 (1968) 652-656
4. de Boer J., and Hoeijmakers J.H. Nucleotide excision repair and human syndromes. Carcinogenesis 21 (2000) 453-460
5. Miller III M.C., Mohrenweiser H.W., and Bell D.A. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120 (2001) 269-280
6. Tomkinson A.E., and Mackey Z.B. Structure and function of mammalian DNA ligases. Mutat Res 407 (1988) 1-9
7. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
8. Cochran W.G. The combination of estimates from different experiments. Biometrics 10 (1954) 101-129
9. Whitehead A., and Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10 (1991) 1665-1667
10. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
11. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
12. Erlich H.A., Gelfand D., and Sninsky J.J. Recent advances in the polymerase chain reaction. Science 252 (1991) 1643-1651
13. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., and Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91 (2000) 865-868
14. Johnson V.J., Yucesoy B., and Luster M.I. Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine 27 (2004) 135-141
15. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91 (1999) 1194-1210
16. Livneh Z. DNA damage control by novel DNA polymerases: translesion replication and mutagenesis. J Biol Chem 276 (2001) 25639-25642
17. Berwick M., and Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92 (2000) 874-897
18. Lippman S.M., and Spitz M.R. Lung cancer chemoprevention: an integrated approach. J Clin Oncol 19 (2001) S74-S82
19. Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K., et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92 (2000) 1764-1772
20. Wei Q., Cheng L., Hong W.K., and Spitz M.R. Reduced DNA repair capacity in lung cancer patients. Cancer Res 56 (1996) 4103-4107
21. Rajaee-Behbahani N., Schmezer P., Risch A., Rittgen W., Kayser K.W., Dienemann H., et al. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer 95 (2001) 86-91
22. Rosenquist A., Zharkov D.O., and Grollman A.P. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci USA 94 (1997) 7429-7434
23. Nishioka K., Ohtsubo T., Oda H., Fujiwara T., Kang D., Sugimachi K., et al. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell 10 (1999) 1637-1652
24. Weiss J.M., Goode E.L., Ladiges W.C., and Ulrich C.M. Polymorphic variation in OGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinogen 42 (2005) 127-141
25. Lee A.J., Hodges N.J., and Chipman J.K. Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7,8-dihydro-2′-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomarkers Prev 14 (2005) 497-505
26. Sugimura H., Kohno T., Wakai K., Nagura K., Genka K., Igarashi H., et al. R hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 8 (1999) 669-674
27. Ito H., Hamajima N., Takezaki T., Matsuo K., Tajima K., Hatooka S., et al. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol 12 (2002) 258-265
28. Sunaga N., Kohno T., Yanagitani N., Sugimura H., Kunitoh H., Tamura T., et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11 (2002) 730-738
29. Lan Q., Mumford J.L., Shen M., Demarini D.M., Bonner M.R., He X., et al. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25 (2004) 2177-2181
30. Wikman H., Risch A., Klimek F., Schmezer P., Spiegelhalder B., Dienemann H., et al. hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a Caucasian population. Int J Cancer 88 (2000) 932-937
31. Hung R.J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 97 (2005) 567-576
32. Le Marchand L., Donlon T., Lum-Jones A., Seifried A., and Wilkens L.R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 409-412
33. Park J., Chen L., Tockman M.S., Elahi A., and Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 14 (2004) 103-109
34. Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162 (2005) 925-942
35. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Sugimura H., et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16 (1998) 3219-3225
36. Dhenaut A., Boiteux S., and Radicella J.P. Characterization of the hOGG1 promoter and its expression during the cell cycle. Mutat Res 461 (2000) 109-118
37. Vogel U., Nexo B.A., Wallin H., Overvad K., Tjonneland A., and Raaschou-Nielsen O. No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem Genet 42 (2004) 453-460
38. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
39. Matullo G., Dunning A.M., Guarrera S., Baynes C., Polidoro S., Garte S., et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27 (2006) 997-1007
40. Sutton A.J., Duval S.J., Tweedie R.L., Abrams K.R., and Jones D.R. Empirical assessment of effect of publication bias on meta-analyses. BMJ 320 (2000) 1574-1577
41. Thompson S.G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309 (1994) 1351-1355
42. Faddy S.C. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 94 (2004) 414
43. Caldecott K.W., Aoufouchi S., Johnson P., and Shall S. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly(ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 24 (1996) 4387-4394
44. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., and de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18 (1998) 3563-3571
45. Whitehouse C.J., Taylor R.M., Thistlethwaite A., Zhang H., Karimi-Busheri F., Lasko D.D., et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104 (2001) 107-117
46. Vidal A.E., Boiteux S., Hickson I.D., and Radicella J.P. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 20 (2001) 6530-6539
47. Thompson L.H., Brookman K.W., Jones J., Allen S.A., and Carrano A.V. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 10 (1990) 6160-6171
48. Shen M.R., Jones I.M., and Mohrenweiser H. Non-conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58 (1998) 604-608
49. Lunn R.M., Langlois G., Hsieh L.L., Thompson C.L., and Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59 (1999) 2557-2561
50. Savas S., Kim D.Y., Ahmad M.F., Shariff M., and Ozcelik H. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol Biomarkers Prev 13 (2004) 801-807
51. Lamerdin J.E., Montgomery M.A., Stilwagen S.A., Scheidecker L.K., Tebbs R.S., Brookman K.W., et al. Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics 25 (1995) 547-554
52. Butkiewicz D., Rusin M., Enewold L., Shields P.G., Chorazy M., and Harris C.C. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22 (2001) 593-597
53. Ratnasinghe D., Yao S.X., Tangrea J.A., Qiao Y.L., Andersen M.R., Barrett M.J., et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10 (2001) 119-123
54. David-Beabes G.L., and London S.J. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 34 (2001) 333-339
55. Divine K.K., Gilliland F.D., Crowell R.E., Stidley C.A., Bocklage T.J., Cook D.L., et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res 461 (2001) 273-278
56. Chen S., Tang D., Xue K., Xu L., Ma G., Hsu Y., et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23 (2002) 1321-1325
57. Park J.Y., Lee S.Y., Jeon H.S., Bae N.C., Chae S.C., Joo S., et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 23-27
58. Misra R.R., Ratnasinghe D., Tangrea J.A., Virtamo J., Andersen M.R., Barrett M., et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191 (2003) 171-178
59. Ito H., Matsuo K., Hamajima N., Mitsudomi T., Sugiura T., Saito T., et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 25 (2004) 1395-1401
60. Popanda O., Schattenberg T., Phong C.T., Butkiewicz D., Risch A., Edler L., et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25 (2004) 2433-2441
61. Harms C., Salama S.A., Sierra-Torres C.H., Cajas-Salazar N., and Au W.W. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 44 (2004) 74-82
62. Zhang X., Miao X., Liang G., Hao B., Wang Y., Tan W., et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65 (2005) 722-726
63. Zhou W., Liu G., Miller D.P., Thurston S.W., Xu L.L., Wain J.C., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 12 (2003) 359-365
64. Schneider J., Classen V., Bernges U., and Philipp M. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Int J Mol Med 16 (2005) 709-716
65. Shen M., Berndt S.I., Rothman N., Mumford J.L., He X., Yeager M., et al. Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res 25 (2005) 537-542
66. Duell E.J., Millikan R.C., Pittman G.S., Winkel S., Lunn R.M., Tse C.K., et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10 (2001) 217-222
67. Nexo B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., et al. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 24 (2003) 899-904
68. Lindahl T. Recognition and processing of damaged DNA. J Cell Sci 19 (1995) S73-S77
69. Bennett R.A., Wilson III D.M., Wong D., and Demple B. Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc Natl Acad Sci USA 94 (1997) 7166-7169
70. Mitra S., Hazra T.K., Roy R., Ikeda S., Biswas T., Lock J., et al. Complexities of DNA base excision repair in mammalian cells. Mol Cell 7 (1997) 305-312
71. Izumi T., Hazra T.K., Boldogh I., Tomkinson A.E., Park M.S., Ikeda S., et al. Requirement for human AP endonuclease 1 for repair of 3-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 21 (2000) 1329-1334
72. Hadi M.Z., Coleman M.A., Fidelis K., Mohrenweiser H.W., and Wilson III D.M. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res 28 (2000) 3871-3879
73. Wilson III D.M., Sofinowski T.M., and McNeill D.R. Repair mechanisms for oxidative DNA damage. Front Biosci 8 (2003) d963-d981
74. Suh D., Wilson III D.M., and Povirk L.F. 3-Phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res 25 (1997) 2495-2500
75. Ramana C.V., Boldogh I., Izumi T., and Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 95 (1998) 5061-5066
76. Wilson III D.M., Takeshita M., Grollman A.P., and Demple B. Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J Biol Chem 270 (1995) 16002-16007
77. Breen A.P., and Murphy J.A. Reactions of oxyl radicals with DNA. J Free Radic Biol Med 18 (1995) 1033-1077
78. Sancar A. DNA repair in humans. Annu Rev Genet 29 (1995) 69-105
79. Kelley M.R., Cheng L., Foster R., Tritt R., Jiang J., Broshears J., et al. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 7 (2001) 824-830
80. Au W.W., Salama S.A., and Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111 (2003) 1843-1850
81. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., and Case L.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22 (2001) 917-922
82. Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 71 (1997) 1-3
83. Nakachi K., Imai K., Hayashi S., Watanabe J., and Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51 (1991) 5177-5180
84. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22 (2001) 1437-1445
85. Palli D., Russo A., Masala G., Saieva C., Guarrera S., Carturan S., et al. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer 94 (2001) 121-127
86. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., and Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Rep 2 (2003) 901-908
87. Abdel-Rahman S.Z., and El-Zein R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 159 (2000) 63-71
88. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., and Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96 (2004) 434-442
89. Healey C.S., Dunning A.M., Teare M.D., Chase D., Parker L., Burn J., et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26 (2000) 362-364
90. Spurdle A.B., Hopper J.L., Chen X., Dite G.S., Cui J., McCredie M.R., et al. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 11 (2002) 413-416
91. Stephens J.C., Schneider J.A., Tanguay D.A., Choi J., Acharya T., Stanley S.E., et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293 (2001) 489-493
92. Judson R., Stephens J.C., and Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics 1 (2000) 15-26
93. Fallin D., Cohen A., Essioux L., Chumakov I., Blumenfeld M., Cohen D., et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 11 (2001) 143-151
94. Khoury M., Beaty T.H., and Cohen B.H. Fundamentals of genetic epidemiology. Monographs in epidemiology and biostatistics (1993), Oxford University Press, New York, NY pp. 144-145
95. Hoh J., Wille A., and Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 11 (2001) 2115-2119
96. Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N. Application of biomarkers in cancer epidemiology (IARC Scientific Publication no. 142), 1997.
97. Vineis P, Maltas M, Lang M, D'Errico A, Caporaso N, Cuzick J, et al. Metabolic polymorphisms and susceptibility to cancer (IARC Scientific Publication no. 148), 1999.
98. Todd J.A. Interpretation of results from genetic studies of multifactorial diseases. Lancet 354 (1999) S115-S116
99. Kiyohara C., Yoshimasu K., Takayama K., and Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 7 (2005) 463-478
100. Kiyohara C., Yoshimasu K., Takayama K., and Nakanishi Y. EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology 17 (2006) 89-99
101. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1513-1530
102. Caporaso N.E. Why have we failed to find the low penetrance genetic constituents of common cancers?. Cancer Epidemiol Biomarkers Prev 11 (2002) 1544-1549
103. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it?. Carcinogenesis 23 (2002) 381-387
104. Kiyohara C., Otsu A., Shirakawa T., Fukuda S., and Hopkin J.M. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37 (2002) 241-256
105. Kiyohara C., Yoshimasu K., Shirakawa T., and Hopkin J.M. Genetic polymorphisms and environmental risk of lung cancer: a review. Rev Environ Health 19 (2004) 15-38